Skarda R T, Muir W W
Department of Veterinary Clinical Sciences, Ohio State University, Columbus 43210-1089, USA.
Am J Vet Res. 1996 Feb;57(2):193-200.
To examine effects of 0.25 mg of xylazine/kg of body weight diluted to a total volume of 6 ml/450 kg with sterile 0.9% NaCl, administered into the epidural space of the sacrococcygeal joint on perineal analgesia, sedation, ataxia, and respiratory and cardiovascular function in standing mares.
Randomized, blinded study, using xylazine (treatment) and 0.9% NaCl (controls). At least 2 weeks elapsed between the treatments.
Eight healthy mares.
Blood samples were drawn. Systemic hemodynamics were determined, including cardiac output and pulmonary arterial, systemic arterial, and right atrial pressures. Two-way ANOVA with repeated measures was used to detect significant (P < 0.05) differences between mean scores of analgesia, sedation, ataxia, and cardiorespiratory variables before and during a 3-hour testing period. Analgesia was determined by lack of sensory perception to electrical stimulation at the perineal dermatome and no response to needle prick stimulation extending from coccyx to S3 dermatomes. Sedation was determined by head ptosis.
Epidurally administered xylazine induced variable bilateral caudal analgesia extending from coccyx to S3, with minimal sedation, ataxia, and cardiovascular and respiratory depression in standing mares. Analgesia was attained at 15 +/- 6 minutes and lasted for 165 to over 180 minutes. Heart and respiratory rates, systolic, diastolic, and mean arterial blood pressure, PCV, hemoglobin concentration, arterial oxygen content, and oxygen transport were decreased after xylazine, but not 0.9% NaCl, treatment. Cardiac output, stroke volume, mean right atrial pressure, mean pulmonary artery pressure, systemic vascular resistance, pulmonary vascular resistance, arterial and mixed venous pH and gas tensions (PO2 and PCO2), oxygen consumption, blood temperature, and rectal temperature did not change significantly (P < 0.05) after epidural administration of xylazine or 0.9% NaCl.
Caudal epidurally administered xylazine (0.25 mg/kg in 6 ml of 0.9% NaCl) can be given safely to induce prolonged (>2 hours) caudal analgesia with minimal sedation, ataxia, and circulatory and respiratory disturbances in conscious, standing mares.
研究将0.25 mg/kg体重的赛拉嗪用无菌0.9%氯化钠溶液稀释至总体积6 ml/450 kg后,注入骶尾关节硬膜外腔对站立母马会阴镇痛、镇静、共济失调以及呼吸和心血管功能的影响。
随机、双盲研究,使用赛拉嗪(治疗组)和0.9%氯化钠溶液(对照组)。两次治疗之间间隔至少2周。
8匹健康母马。
采集血样。测定全身血流动力学,包括心输出量以及肺动脉、体动脉和右心房压力。采用重复测量的双向方差分析来检测在3小时测试期之前和期间镇痛、镇静、共济失调以及心肺变量平均得分之间的显著差异(P < 0.05)。通过对会阴皮节的电刺激缺乏感觉以及对从尾骨到S3皮节的针刺刺激无反应来确定镇痛效果。通过头部下垂来确定镇静效果。
硬膜外注射赛拉嗪可在站立母马中诱导从尾骨到S3的双侧可变尾部镇痛,同时镇静、共济失调以及心血管和呼吸抑制最小。镇痛在15±6分钟时达到,持续165至超过180分钟。赛拉嗪治疗后,心率、呼吸频率、收缩压、舒张压和平均动脉血压、红细胞压积、血红蛋白浓度、动脉血氧含量和氧输送均降低,但0.9%氯化钠溶液治疗后未出现此情况。硬膜外注射赛拉嗪或0.9%氯化钠溶液后,心输出量、每搏输出量、平均右心房压力、平均肺动脉压力、体循环血管阻力、肺循环血管阻力、动脉和混合静脉pH值及气体张力(PO2和PCO2)、氧消耗、血温和直肠温度均无显著变化(P < 0.05)。
硬膜外给予赛拉嗪(0.25 mg/kg溶于6 ml 0.9%氯化钠溶液)可安全地诱导清醒站立母马产生持续时间长(>2小时)的尾部镇痛,同时镇静、共济失调以及循环和呼吸干扰最小。